Literature DB >> 22058210

t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and up-regulates GPR34.

Mathijs Baens1, Julio Finalet Ferreiro, Thomas Tousseyn, Helena Urbankova, Lucienne Michaux, Laurence de Leval, Daan Dierickx, Pascal Wolter, Xavier Sagaert, Peter Vandenberghe, Christiane De Wolf-Peeters, Iwona Wlodarska.   

Abstract

Genetic events underlying pathogenesis of nodal and extranodal marginal zone lymphoma are not completely understood. We report here a novel t(X;14)(p11.4;q32.33) identified in 4 lymphoma cases: 2 with a mucosa-associated lymphoid tissue lymphoma, one with a nodal marginal zone lymphoma and one with gastric diffuse large B-cell lymphoma. In all cases, lymphoma evolved from a previous auto-immune disorder. Fluorescence in situ hybridization and molecular studies showed that t(X;14), which is mediated by immunoglobulin heavy chain locus, targets the GPR34 gene at Xp11.4. Upregulation of GPR34 mRNA and aberrant expression of GPR34 protein has been demonstrated in 3 presented cases by quantitative real-time polymerase chain reaction and immunohistochemistry, respectively. GPR34 belongs to the largest family of cell surface molecules involved in signal transmission that play important roles in many physiological and pathological processes, including tumorigenesis. Although functional consequences of t(X;14) have not been identified, our studies suggest that up-regulated GPR34 activate neither nuclear factor-κB nor ELK-related tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22058210      PMCID: PMC3269475          DOI: 10.3324/haematol.2011.052639

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  12 in total

Review 1.  MALT lymphoma: from morphology to molecules.

Authors:  Peter G Isaacson; Ming-Qing Du
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

Review 2.  Oncogenic activation of NF-kappaB.

Authors:  Louis M Staudt
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

3.  Oncogenically active MYD88 mutations in human lymphoma.

Authors:  Vu N Ngo; Ryan M Young; Roland Schmitz; Sameer Jhavar; Wenming Xiao; Kian-Huat Lim; Holger Kohlhammer; Weihong Xu; Yandan Yang; Hong Zhao; Arthur L Shaffer; Paul Romesser; George Wright; John Powell; Andreas Rosenwald; Hans Konrad Muller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; J R Cook; Denny D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Nature       Date:  2010-12-22       Impact factor: 49.962

Review 4.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

5.  Discovery of three novel orphan G-protein-coupled receptors.

Authors:  A Marchese; M Sawzdargo; T Nguyen; R Cheng; H H Heng; T Nowak; D S Im; K R Lynch; S R George; B F O'dowd
Journal:  Genomics       Date:  1999-02-15       Impact factor: 5.736

6.  Genomic and supragenomic structure of the nucleotide-like G-protein-coupled receptor GPR34.

Authors:  Eva Engemaier; Holger Römpler; Torsten Schöneberg; Angela Schulz
Journal:  Genomics       Date:  2005-12-09       Impact factor: 5.736

7.  A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma.

Authors:  E Chanudet; Y Huang; K Ichimura; G Dong; R A Hamoudi; J Radford; A C Wotherspoon; P G Isaacson; J Ferry; M-Q Du
Journal:  Leukemia       Date:  2009-11-12       Impact factor: 11.528

Review 8.  Marginal zone B-cell lymphomas.

Authors:  Xavier Sagaert; Thomas Tousseyn
Journal:  Discov Med       Date:  2010-07       Impact factor: 2.970

9.  A novel subgroup of class I G-protein-coupled receptors.

Authors:  T Schöneberg; A Schulz; R Grosse; R Schade; P Henklein; G Schultz; T Gudermann
Journal:  Biochim Biophys Acta       Date:  1999-07-07

Review 10.  Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression.

Authors:  Shuyu Li; Shuguang Huang; Sheng-Bin Peng
Journal:  Int J Oncol       Date:  2005-11       Impact factor: 5.650

View more
  9 in total

Review 1.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

2.  t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth.

Authors:  Stephen M Ansell; Takashi Akasaka; Ellen McPhail; Michelle Manske; Esteban Braggio; Tammy Price-Troska; Steven Ziesmer; Frank Secreto; Rafael Fonseca; Mamta Gupta; Mark Law; Thomas E Witzig; Martin J S Dyer; Ahmet Dogan; James R Cerhan; Anne J Novak
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

Review 3.  Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review.

Authors:  Michiel van den Brand; J Han J M van Krieken
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

4.  G-protein coupled receptor 34 knockdown impairs the proliferation and migration of HGC-27 gastric cancer cells in vitro.

Authors:  Zhong-Tian Jin; Kun Li; Mei Li; Zhi-Gang Ren; Fu-Shun Wang; Ji-Ye Zhu; Xi-Sheng Leng; Wei-Dong Yu
Journal:  Chin Med J (Engl)       Date:  2015-02-20       Impact factor: 2.628

Review 5.  Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma.

Authors:  Max I Schreuder; Michiel van den Brand; Konnie M Hebeda; Patricia J T A Groenen; J Han van Krieken; Blanca Scheijen
Journal:  J Hematop       Date:  2017-09-25       Impact factor: 0.196

Review 6.  Recent advances in understanding the biology of marginal zone lymphoma.

Authors:  Francesco Bertoni; Davide Rossi; Emanuele Zucca
Journal:  F1000Res       Date:  2018-03-28

7.  Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites.

Authors:  Sarah Moody; Joe Sneath Thompson; Shih-Sung Chuang; Hongxiang Liu; Markus Raderer; George Vassiliou; Iwona Wlodarska; Fangtian Wu; Sergio Cogliatti; Alistair Robson; Margaret Ashton-Key; Yingwen Bi; John Goodlad; Ming-Qing Du
Journal:  Haematologica       Date:  2018-04-19       Impact factor: 9.941

Review 8.  Recent Advances in the Genetic of MALT Lymphomas.

Authors:  Juan José Rodríguez-Sevilla; Antonio Salar
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639

Review 9.  Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid.

Authors:  Jumpei Omi; Kuniyuki Kano; Junken Aoki
Journal:  Cell Biochem Biophys       Date:  2021-06-15       Impact factor: 2.194

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.